CRXM Gene Biotherapeutics
- 0.000001
- 0.0000000.00%
Gene Biotherapeutics News
Gene Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Christopher J. Jemapete(6.2%)
Gene Biotherapeutics | 10-K/A: Annual report (Amendment)
Gene Biotherapeutics | 10-K: FY2020 Annual Report
Gene Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Gene Biotherapeutics | 10-Q: Quarterly report
Gene Biotherapeutics | 10-Q: Quarterly report
Gene Biotherapeutics | 10-Q: Quarterly report
Gene Biotherapeutics | 8-K/A: Current report (Amendment)
Gene Biotherapeutics | 8-K: Current report
Gene Biotherapeutics | 8-K: Current report
Gene Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Christopher J. Jemapete(8.1%)
Gene Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Jemapete Christopher J
Gene Biotherapeutics | 8-K: Current report
Gene Biotherapeutics | 10-K: Annual report
Gene Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Jemapete Christopher J
Gene Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Christopher J. Jemapete(27.6%)
Gene Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Christopher J. Jemapete(24.2%)
Gene Biotherapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Jemapete Christopher J
Gene Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Christian F. Coluccio(5.0%)
Gene Biotherapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner MULYE NIRMAL
Analysis
Price Target
No Data
